Your browser doesn't support javascript.
loading
Rationale and Design of the ADIDAS Study: Association Between Dapagliflozin-Induced Improvement and Anemia in Heart Failure Patients.
Zeng, Jianping; Zhu, Yunlong; Zhao, Wenjiao; Wu, Mingxing; Huang, Haobo; Huang, He; Wu, ChunFeng; Zhou, XiaoLin; Zhou, ShengHua; Wang, ChengMing; Yin, Kai; Xu, FangHua; Cai, ZhiQiang; Li, Xinyang; Cheng, Huiheng; Xie, Youwen; Tan, Zhuqing; Hu, Xiaoyong; Liao, Dexiang; Wang, Yingchun.
Afiliação
  • Zeng J; Department of Cardiology, Xiangtan Central Hospital, Xiangtan, Hunan, 411100, People's Republic of China. xhjiang2@hnust.edu.cn.
  • Zhu Y; Department of Cardiology, Xiangtan Central Hospital, Xiangtan, Hunan, 411100, People's Republic of China.
  • Zhao W; Department of Cardiology, Xiangtan Central Hospital, Xiangtan, Hunan, 411100, People's Republic of China.
  • Wu M; Department of Cardiology, Xiangtan Central Hospital, Xiangtan, Hunan, 411100, People's Republic of China.
  • Huang H; Department of Cardiology, Xiangtan Central Hospital, Xiangtan, Hunan, 411100, People's Republic of China.
  • Huang H; Department of Cardiology, Xiangtan Central Hospital, Xiangtan, Hunan, 411100, People's Republic of China.
  • Wu C; Department of Cardiology, Xiangtan Central Hospital, Xiangtan, Hunan, 411100, People's Republic of China.
  • Zhou X; Department of Cardiology, Xiangtan Central Hospital, Xiangtan, Hunan, 411100, People's Republic of China.
  • Zhou S; Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, People's Republic of China.
  • Wang C; Department of Cardiology, Zhuzhou Central Hospital, Zhuzhou, Hunan, 412000, People's Republic of China.
  • Yin K; Department of Cardiology, The First People's Hospital of Xiangtan City, Xiangtan, Hunan, 411100, People's Republic of China.
  • Xu F; Department of Cardiology, The First People's Hospital of Xiangtan City, Xiangtan, Hunan, 411100, People's Republic of China.
  • Cai Z; Department of Cardiology, The People's Hospital of Xiangtan County, Xiangtan, Hunan, 411100, People's Republic of China.
  • Li X; Department of Cardiology, Xiangxiang People's Hospital, Xiangtan, Hunan, 411400, People's Republic of China.
  • Cheng H; Department of Cardiology, The Second People's Hospital of Xiangxiang, Xiangtan, Hunan, 411400, People's Republic of China.
  • Xie Y; Department of Cardiology, JiangNan Hospital in Xiangtan, Xiangtan, Hunan, 411100, People's Republic of China.
  • Tan Z; Department of Cardiology, Shaoshan People's Hospital, Xiangtan, Hunan, 411300, People's Republic of China.
  • Hu X; Department of Cardiology, The Third People's Hospital of Xiangtan, Xiangtan, Hunan, 411100, People's Republic of China.
  • Liao D; Department of Cardiology, The First People's Hospital of Zhuzhou County, Zhuzhou, Hunan, 412000, People's Republic of China.
  • Wang Y; Department of Cardiology, The Second People's Hospital of Xiangtan, Xiangtan, Hunan, 411100, People's Republic of China.
Cardiovasc Drugs Ther ; 36(3): 505-509, 2022 06.
Article em En | MEDLINE | ID: mdl-33779938
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article